New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 22, 2014
07:28 EDTTGTXTG Therapeutics added to Focus List at Roth Capital
Roth Capital added TG Therapeutics to the Focus List based on exceptions the remainder of 2104 will be transformational with upcoming data catalysts and improved visibility from the competitive landscape. Shares are Buy rated with a $15 price target.
News For TGTX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 10, 2014
10:33 EDTTGTXTG Therapeutics price target raised to $33 from $25 at Roth Capital
December 9, 2014
11:15 EDTTGTXTG Therapeutics announces data of TG-1101 in combination with TGR-1202
Subscribe for More Information
December 8, 2014
13:45 EDTTGTXTG Therapeutics says TG-1101 well tolerated in Phase 2 study
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use